← Leaderboards
Shinji Makino
University Of Texas Medical Br Galveston
$11,956,927
Attributed
$11,956,927
Total exposure
15
Grants
13
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $1.1M · FY2005–25$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$11,956,927 · 15
By mechanism
R01$8,979,464 · 6
R21$2,412,833 · 6
U54$415,630 · 2
R03$149,000 · 1
Top collaborators
No co-investigators on record.
Others in their field
Top investigators on “Virus Replication”
- Constance Ann Benson · University Of California, San Diego$187,673,896
- Judith S. Currier · University Of California Los Angeles$137,892,773
- Joseph J. Eron · Univ Of North Carolina Chapel Hill$137,892,773
- Barton F Haynes · Duke University$110,672,613
- Charles M. Rice · Rockefeller University$53,754,576
- Rama Rao Amara · Emory University$53,347,944
Research focus
Virus ReplicationVirusGenomeViralProteinsCellsMessenger RnaProductionViral RnaMutantCountryViral ProteinsMediatingGene ExpressionPathogenicityPlayInterferonsVirulence FactorsInfectionSevere Acute Respiratory SyndromeSars CoronavirusRna Chemical SynthesisMurine Hepatitis VirusGenes
Grant awards (42)
Investigation of RNA packaging in Rift Valley fever virus$636,101
R01 · FY2025 · AI · contact PI
Modulation of viral genome packaging in Rift Valley fever virus$200,000
R21 · FY2025 · AI · contact PI
Modulation of viral genome packaging in Rift Valley fever virus$240,000
R21 · FY2024 · AI · contact PI
Interplay between coronaviruses and nonsense-mediated mRNA decay pathway$309,206
R01 · FY2023 · AI · contact PI
Interplay between coronaviruses and nonsense-mediated mRNA decay pathway$309,206
R01 · FY2022 · AI · contact PI
Interplay between coronaviruses and nonsense-mediated mRNA decay pathway$309,206
R01 · FY2021 · AI · contact PI
Mechanism of viral RNP recognition by the envelope glycoprotein and its role in RNA segment packaging in Rift Valley Fever phlebovirus$197,500
R21 · FY2021 · AI · contact PI
Interplay between coronaviruses and nonsense-mediated mRNA decay pathway$309,206
R01 · FY2020 · AI · contact PI
Mechanism of viral RNP recognition by the envelope glycoprotein and its role in RNA segment packaging in Rift Valley Fever phlebovirus$237,000
R21 · FY2020 · AI · contact PI
New Paradigm for Host and Viral Gene Regulation by MERS Coronavirus nsp1$387,500
R01 · FY2019 · AI · contact PI
New Paradigm for Host and Viral Gene Regulation by MERS Coronavirus nsp1$454,256
R01 · FY2018 · AI · contact PI
Rational Development of a Novel Attenuated Rift Valley Fever Virus Vaccine$193,750
R21 · FY2018 · AI · contact PI
New Paradigm for Host and Viral Gene Regulation by MERS Coronavirus nsp1$456,581
R01 · FY2017 · AI · contact PI
Rational Development of a Novel Attenuated Rift Valley Fever Virus Vaccine$232,500
R21 · FY2017 · AI · contact PI
New Paradigm for Host and Viral Gene Regulation by MERS Coronavirus nsp1$387,500
R01 · FY2016 · AI · contact PI
Analysis of Coronavirus-Host Cell Interactions$382,500
R01 · FY2016 · AI · contact PI
Development of Safer,Live Attenuated Rift Valley Fever Vaccines$193,750
R21 · FY2016 · AI · contact PI
New Paradigm for Host and Viral Gene Regulation by MERS Coronavirus nsp1$46,571
R01 · FY2016 · AI · contact PI
Analysis of Coronavirus-Host Cell Interactions$442,380
R01 · FY2015 · AI · contact PI
New Paradigm for Host and Viral Gene Regulation by MERS Coronavirus nsp1$387,500
R01 · FY2015 · AI · contact PI
Development of Safer,Live Attenuated Rift Valley Fever Vaccines$232,500
R21 · FY2015 · AI · contact PI
Analysis of Coronavirus-Host Cell Interactions$382,500
R01 · FY2014 · AI · contact PI
Development of a Novel Rift Valley Fever Virus Vaccine$193,333
R21 · FY2014 · AI · contact PI
Analysis of Coronavirus-Host Cell Interactions$30,327
R01 · FY2014 · AI · contact PI
Analysis of Coronavirus-Host Cell Interactions$359,550
R01 · FY2013 · AI · contact PI
Development of a Novel Rift Valley Fever Virus Vaccine$231,750
R21 · FY2013 · AI · contact PI
Analysis of Coronavirus-Host Cell Interactions$382,500
R01 · FY2012 · AI · contact PI
Analysis of SARS Coronavirus-Host Cell Interactions$290,366
R01 · FY2011 · AI · contact PI
Analysis of SARS Coronavirus-Host Cell Interactions$293,299
R01 · FY2010 · AI · contact PI
Analysis of SARS Coronavirus-Host Cell Interactions$296,262
R01 · FY2009 · AI · contact PI
Toward Control of Rift Valley Fever Virus Replication$152,129
U54 · FY2009 · AI · contact PI
Analysis of SARS Coronavirus-Host Cell Interactions$296,262
R01 · FY2008 · AI · contact PI
Toward Control of Rift Valley Fever Virus Replication$263,501
U54 · FY2008 · AI · contact PI
Analysis of SARS Coronavirus-Host Cell Interactions$302,000
R01 · FY2007 · AI · contact PI
Molecular Studies of Coronavirus Replication$327,372
R01 · FY2006 · AI · contact PI
Molecular Studies of Coronavirus Replication$335,250
R01 · FY2005 · AI
Molecular Studies of Coronavirus Replication$335,250
R01 · FY2004 · AI
Molecular Studies of Coronavirus Replication$335,250
R01 · FY2003 · AI
Developing Efficient HCV Replication Cell Culture System$74,500
R03 · FY2003 · AI
Molecular Studies of Coronavirus Replication$195,563
R01 · FY2002 · AI
Developing Efficient HCV Replication Cell Culture System$74,500
R03 · FY2002 · AI
Molecular Studies of Coronavirus Replication$260,750
R21 · FY2001 · AI